CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 42.569
AS - Asia 24.555
EU - Europa 20.647
SA - Sud America 4.983
AF - Africa 705
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 41
Totale 93.551
Nazione #
US - Stati Uniti d'America 41.687
SG - Singapore 8.796
CN - Cina 7.988
UA - Ucraina 5.138
BR - Brasile 4.178
IT - Italia 4.110
HK - Hong Kong 2.974
DE - Germania 2.709
FI - Finlandia 1.587
VN - Vietnam 1.459
PL - Polonia 1.455
FR - Francia 1.321
GB - Regno Unito 1.188
TR - Turchia 992
RU - Federazione Russa 920
IE - Irlanda 885
IN - India 674
BD - Bangladesh 486
CA - Canada 451
SE - Svezia 419
AR - Argentina 294
MX - Messico 257
NL - Olanda 188
IQ - Iraq 185
ZA - Sudafrica 181
AT - Austria 168
ID - Indonesia 151
ES - Italia 137
EC - Ecuador 134
JP - Giappone 119
PK - Pakistan 118
CO - Colombia 97
SA - Arabia Saudita 92
BE - Belgio 80
BF - Burkina Faso 72
MA - Marocco 72
UZ - Uzbekistan 72
VE - Venezuela 70
PY - Paraguay 62
CZ - Repubblica Ceca 58
CL - Cile 54
MU - Mauritius 54
LT - Lituania 53
NG - Nigeria 53
EG - Egitto 47
AU - Australia 45
KE - Kenya 45
JO - Giordania 44
JM - Giamaica 43
EU - Europa 38
PH - Filippine 36
UY - Uruguay 36
CH - Svizzera 35
IR - Iran 35
AE - Emirati Arabi Uniti 34
AZ - Azerbaigian 33
ET - Etiopia 32
IL - Israele 32
TN - Tunisia 32
PE - Perù 31
GH - Ghana 30
CR - Costa Rica 27
MY - Malesia 27
PT - Portogallo 25
NP - Nepal 24
DZ - Algeria 23
AL - Albania 20
HN - Honduras 20
RO - Romania 19
BO - Bolivia 18
KZ - Kazakistan 18
OM - Oman 18
TH - Thailandia 17
LB - Libano 16
PA - Panama 15
TT - Trinidad e Tobago 15
DO - Repubblica Dominicana 14
KR - Corea 14
HR - Croazia 13
BH - Bahrain 11
CM - Camerun 11
GR - Grecia 11
KG - Kirghizistan 11
LK - Sri Lanka 11
RS - Serbia 11
BG - Bulgaria 10
BY - Bielorussia 10
NI - Nicaragua 10
SK - Slovacchia (Repubblica Slovacca) 10
CI - Costa d'Avorio 9
MD - Moldavia 9
PR - Porto Rico 9
PS - Palestinian Territory 9
BB - Barbados 8
HU - Ungheria 8
KH - Cambogia 8
AM - Armenia 7
EE - Estonia 7
LV - Lettonia 7
SI - Slovenia 7
Totale 93.403
Città #
Singapore 4.705
Jacksonville 3.638
Fairfield 3.588
Ashburn 3.531
Hong Kong 2.962
Woodbridge 2.881
Chandler 2.142
Wilmington 2.003
Houston 1.782
San Jose 1.631
Princeton 1.601
The Dalles 1.537
Cambridge 1.467
Ann Arbor 1.463
Seattle 1.455
Beijing 1.452
Warsaw 1.433
Nanjing 1.235
New York 1.106
Dublin 872
Helsinki 842
Lauterbourg 800
Los Angeles 799
Istanbul 785
Ho Chi Minh City 488
Munich 443
Buffalo 431
Nanchang 426
Brescia 421
Des Moines 412
Milan 412
São Paulo 378
Council Bluffs 357
Moscow 319
Dallas 317
Shenyang 316
Changsha 295
Hanoi 283
Hebei 264
Chicago 245
San Diego 238
Tianjin 236
Jinan 210
Dearborn 202
Jiaxing 197
Shanghai 196
Redondo Beach 195
San Francisco 180
Orem 179
Santa Clara 179
Nuremberg 159
London 158
Hangzhou 151
Rome 145
Kunming 144
Rio de Janeiro 141
Toronto 130
Verona 125
Boardman 119
Frankfurt am Main 117
Turku 116
Montreal 115
Tokyo 109
Mexico City 101
Brooklyn 99
Chennai 96
Kocaeli 94
Johannesburg 88
Zhengzhou 88
Denver 87
Guangzhou 86
Belo Horizonte 83
Mcallen 83
Phoenix 82
Brussels 78
Ningbo 78
Brasília 77
Atlanta 76
Manchester 73
Boston 72
Stockholm 71
Vienna 71
Lanzhou 69
Tashkent 68
Lancaster 67
Ouagadougou 67
Baghdad 66
Haiphong 66
Salt Lake City 64
Romola 61
Jakarta 60
Poplar 59
Curitiba 58
Dong Ket 58
Norwalk 56
Amsterdam 55
Da Nang 55
Mumbai 55
Washington 54
Porto Alegre 53
Totale 57.932
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 478
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 417
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 295
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 292
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 271
Proceedings of the IV Congress of the University Network for Development Cooperation (CUCS) “Rinforzare il capitale umano nei paesi a risorse limitate: health and wealth for all by the year 2030” 259
Cos’è la Medicina Tropicale 250
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data 248
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 243
Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 242
Arboviral and other illnesses in travellers returning from Brazil, june 2013 to may 2016: Implications for the 2016 olympic and paralympic games 240
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 235
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 227
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 224
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 221
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 220
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: Results from the Italian MASTER Cohort 214
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection 209
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 206
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 204
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 203
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 202
Towards tuberculosis elimination: An action framework for low-incidence countries 202
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 202
Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy 202
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 201
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 201
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 199
A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from singapore 199
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 191
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 190
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV 187
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 181
A first update on mapping the human genetic architecture of COVID-19 179
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 179
Malaria chemoprophylactic recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study 179
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 179
Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study 179
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 177
Mapping the human genetic architecture of COVID-19 176
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 176
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 176
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 175
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 174
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 174
Non-typhoidal Salmonella aortitis 173
Louse-borne relapsing fever in a refugee from Mali 172
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 171
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 170
ABDOMINAL AORTITIS AND ANEURYSM IMPENDING RUPTURE DURING PNEUMOCOCCAL MENINGITIS 170
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 170
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 169
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 168
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 168
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 167
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 166
Accidental and transfusion malaria in Italy 165
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 165
Advances in the treatment of malaria 165
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 165
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy 165
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 164
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 164
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study 164
Epidemiology of malaria in endemic areas 162
Differential diagnosis of illness in travelers arriving from sierra Leone, Liberia, or guinea: A cross-sectional study from the Geosentinel surveillance network 162
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 162
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 162
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 162
A COPD case-finding program in a large cohort of HIV-infected persons 162
Migration Medicine: the Challenge of Tuberculosis 160
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 160
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 160
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 159
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 159
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 159
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 158
A Case of Rickettsia felis Infection Imported from Nepal 158
An explainable model of host genetic interactions linked to COVID-19 severity 157
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea 157
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 157
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 156
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 156
Correction to: Acute epididymo-orchitis due to Salmonella Typhi in a young man from Bangladesh. 156
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 156
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 155
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 155
A Strange Manifestation of Malaria in a Native Nigerian Boy 155
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 154
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 154
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 154
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C 154
Simultaneous Diagnosis of Acute Crohn's Disease and Endometriosis in a Patient Affects HIV 154
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 153
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 153
Filariasis in travelers presenting to the Geosentinel Surveillance Network 153
Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean 151
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from Non-EU countries in northern Italy 150
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 150
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 150
Totale 18.694
Categoria #
all - tutte 489.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 489.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021300 0 0 0 0 0 0 0 0 0 0 0 300
2021/20225.840 307 1.165 114 395 89 327 250 459 330 693 506 1.205
2022/20236.001 918 106 104 597 541 1.597 18 623 927 50 232 288
2023/20245.249 378 176 396 331 222 926 176 205 1.326 69 108 936
2024/202514.206 121 74 132 1.544 1.695 1.230 1.297 596 1.556 1.247 2.930 1.784
2025/202627.890 2.578 3.709 2.113 4.285 2.602 1.844 4.075 1.139 1.825 2.253 995 472
Totale 94.698